Cetera Trust Company’s AbbVie ABBV Stock Holding History

Cetera Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$145K	Hold	668	–	–	0.08%	183
2025 Q4	$153K	Hold	668	–	–	0.08%	178
2025 Q3	$155K	Hold	668	–	–	0.09%	186
2025 Q2	$124K	Hold	668	–	–	0.07%	194
2025 Q1	$140K	Hold	668	–	–	0.09%	182
2024 Q4	$119K	Hold	668	–	–	0.08%	191
2024 Q3	$132K	Hold	668	–	–	0.08%	195
2024 Q2	$115K	Hold	668	–	–	0.07%	201
2024 Q1	$122K	Hold	668	–	–	0.07%	196
2023 Q4	$104K	Buy	+668	New	+$97.4K	0.06%	197

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cetera Trust Company's ABBV Position: Q1 2026 in Review

Cetera Trust Company held its AbbVie (ABBV) position steady in Q1 2026 at 668 shares worth $145K. The position accounts for 0.08% of the portfolio, ranked #183.

Cetera Trust Company first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $155K in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Cetera Trust Company held 668 shares of AbbVie worth $145K as of Q1 2026.
Cetera Trust Company left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.08% of Cetera Trust Company's portfolio in Q1 2026, its #183 holding.
Cetera Trust Company first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Cetera Trust Company's AbbVie position peaked at $155K in Q3 2025.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cetera Trust Company's 13F filing for Q1 2026, filed 8 May 2026.